---
schema_version: "secwatch.filing_event.v1"
accession: "0001079973-25-000764"
form_type: "8-K"
ticker: "TOI"
cik: "0001799191"
company_name: "Oncology Institute, Inc."
filed_at: "2025-05-07T23:59:59+00:00"
generated_at: "2026-05-22T08:41:44.857714+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# The Oncology Institute COO Jeremy Castle resigns effective May 30, 2025

## Summary
- Jeremy Castle provided notice of resignation as COO, effective May 30, 2025.
- Resignation not due to any disagreement with the Company on operations, policies, or practices.
- No successor or interim arrangement announced.

## SEC filing metadata
- accession: 0001079973-25-000764
- form_type: 8-K
- ticker: TOI
- cik: 0001799191
- company_name: Oncology Institute, Inc.
- filed_at: 2025-05-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799191/000107997325000764/0001079973-25-000764-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799191/000107997325000764/toi_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001079973-25-000764
- JSON: https://secwatch.observer/filing/0001079973-25-000764.json
- Plain text: https://secwatch.observer/filing/0001079973-25-000764.txt

## Source-grounded claims
- claim_id: dec50a9e1a
  claim: Jeremy Castle resigned as Chief Operating Officer at Oncology Institute, Inc..
  evidence_excerpt: On May 2, 2025, Jeremy Castle provided notice of his resignation as Chief Operating Officer of The Oncology Institute, Inc. (the “Company”), effective as of May 30, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1799191/000107997325000764/0001079973-25-000764-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.